- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to characterize the pharmacokinetics of 10 and 20 mg of rivaroxaban administered as an oral suspension in comparison to a 10 mg immediate release tablet. The potential for a food effect will be investigated for the 20 mg oral suspension
Critère d'inclusion
- healthy volunteers (Prevention and teatment of thromboembolic disorders)